GlassScriptPhysician profile
Amy S Schaeffer
NPI 1316353097
$1,548.11
in general payments reported to CMS, 2019-2025
13 companies · $518 in 2025
The $518 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $107 · 2023: $122 · 2024: $612 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.84 |
| Education | $161.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $571.56 | 2024-2025 | Rybrevant, Carvykti, Tecvayli |
| Alexion Pharmaceuticals, INC. | $214.22 | 2022-2025 | Soliris, Ultomiris |
| E.R. Squibb & Sons, L.L.C. | $126.83 | 2021-2025 | |
| Rigel Pharmaceuticals, INC. | $124.74 | 2024 | Tavalisse, Rezlidhia |
| Incyte Corporation | $122.06 | 2023 | Jakafi |
| Sobi, INC | $119.21 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $107.09 | 2021 | |
| Jazz Pharmaceuticals INC. | $52.98 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $34.07 | 2025 | Lynozyfic |
| Ipsen Biopharmaceuticals, INC | $25.44 | 2025 | Onivyde |
| Scpharmaceuticals INC. | $20.88 | 2024 | |
| Celgene Corporation | $16.81 | 2021 | |
| Seagen INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.